Christie is a PhD student in the Immunology program at Stanford. She received her bachelor’s in Computer Science and Genetics from Rutgers University in 2017. During this time, she worked in the lab of Dr. Lei Yu, studying the molecular pathway for neuropathic pain therapeutic targets. After graduation, she joined Dr. Miriam Merad’s lab at the Icahn School of Medicine at Mount Sinai, where she optimized multi-dimensional assays for use in immunotherapy clinical trials. Christie is interested in implementing cutting-edge technologies to better understand immunological changes in disease.

Back to front

Peter is PhD student in the Cancer Biology program. He received his bachelor’s degree from Princeton in 2017 and worked as a computational biologist at the Broad Institute following graduation. As a jointed advised student in the Satpathy and Bassik labs, Peter is interested in using single cell technologies and functional genomics to dissect cell communication circuits in the tumor microenvironment.

Back to front

Austin is a rotating graduate student in the Genetics program at Stanford. He studied Computer Science as an undergraduate at Santa Clara University. Before graduate school, he worked in software at 10x Genomics and then in Dr. Rahul Satija’s lab developing tools for single cell and spatial genomics. Going forward, he hopes to apply multiomic methods with different kinds of perturbations to build better cell therapies and predictably manipulate cell function.

Back to front

Kamir received his PhD in Biomedical Sciences from the University of California San Francisco in 2020. His PhD work in the Spitzer lab fused experimental and computational immunology to decipher the dynamic regulation of CD8 T cell priming in cancer and infection. As a CRI Irvington Postdoctoral Fellow in the Satpathy lab, Kamir aims to develop and apply lineage recording tools combined with multimodal single cell omics to decode the regulatory logic guiding the differentiation of cytotoxic CD4 T cells. 

Back to front

Siva is a Fellow in Pediatric Rheumatology. He is a board-certified pediatrician and completed combined MD-PhD training at the University of Washington and Fred Hutchinson Cancer Center in Seattle. His thesis research focused on developing genomic technologies for chromatin profiling and centromere biology. Siva’s current clinical and research interests include the genetics of immune dysregulation. In the Satpathy lab, he aims to develop and apply new methods to better understand clonal dynamics in autoimmune disease.

Back to front

Saba is a Life Science Research Professional in the Satpathy Lab at the Stanford University School of Medicine. Saba graduated from UC Berkeley with a BA emphasizing in immunology and molecular medicine in 2023. Throughout undergrad, she worked in Dr. James Bayrer’s lab at UCSF researching the function of human LRH-1 in bile acid transport in the gut intestinal epithelium and its correlation to fatty liver disease. In the Satpathy Lab, Saba is interested in how immunology can be applied in cancer therapies through cancer immunotherapy.

Back to front

Chris received his PhD from University of California San Francisco in 2021. As a graduate student in the Gartner lab, Chris developed computational and molecular tools for single-cell transcriptomics and epigenomics, including DoubletFinder, MULTI-seq, and MULTI-ATAC-seq. He additionally used these methods to perform high-throughput immunomodulatory drug screens at single-cell resolution. As a postdoctoral fellow in the Satpathy lab, Chris will apply his background in single-cell genomics, immunology, and computational biology to fundamental questions in the cancer immunology field, including how tumors reprogram the immune system during metastasis.

Back to front

Lauren is a Center Administrator in the Department of Pathology, supporting three Centers funded by NHGRI and NIAID. Lauren previously served as the Assistant Director of the Translational Research Institute on Pain in Later Life at Weill Cornell Medicine, and most recently as the Research Program Manager for the Patient Centered Injury Prevention Lab at University of Colorado School of Medicine. 

Back to front

Max is a PhD student in the Satpathy Lab. He is a first-year graduate student in the genetics program. He graduated from Harvard University with a Bachelor’s Degree in Chemical and Physical Biology in 2019. During his undergraduate studies, he worked in Dr. Vijay Kuchroo’s lab and Dr. David Liu’s lab.

Back to front

Laura earned her doctoral degree from University of Regensburg in the lab of Matthias Edinger & Petra Hoffmann, where she conducted experimental thesis work on engineering regulatory T cells as an adoptive cellular therapy for GvHD. As a pediatric resident at the University Hospital Frankfurt her clinical work in the department of Stem Cell Transplantation & Immunology of Peter Bader focused on adoptive cellular therapies including CAR-T cell therapy. In the lab of Eva Rettinger she has investigated cytokine-induced killer cells as effector cells for CAR engineering in solid tumors. As a post-doc in the Satpathy lab she will continue her research in pediatric immunotherapy, exploring the diversity of immune effector cells and their trajectories to enhance the effectiveness of targeted immunotherapies in solid tumors.

Back to front

Back to front

Michael completed his Ph.D. at the Garvan Institute of Medical Research (Sydney, AUS), where he applied mass-spectrometry based proteomic tools to study the role of the stroma in cancer development and metastasis. Michael continued his training at the Albert Einstein College of Medicine (New York, USA) where he utilized advanced intravital microscopy methods to investigate how the immune system regulates metastatic efficiency. As a CRI fellow, Michael will implement immunogenomics to understand the role of the aging adaptive immune system in solid tumor patients.

Back to front

Colin is a PhD student in the Immunology Program. He graduated from Tufts University in 2019 with a degree in Biology. While at Tufts, he studied the functional role of tandem repeat regions in proteins. Before starting at Stanford, Colin worked at SQZ Biotech developing a cell therapy to induce antigen-specific tolerance for the treatment of autoimmune diseases. In the Satpathy lab, he is interested in addressing basic hypotheses in T cell biology by combining fundamental immunological systems with high-throughput genomic techniques. 

Back to front

Katherine completed her PhD in 2011 at the University of Florida studying early fate specification in mouse embryonic stem cells in the laboratory of Naohiro Terada, MD,PhD. Upon graduation, she co-founded the Center for Cellular Reprogramming at the University to reprogram somatic cells to iPSCs and subsequently differentiate iPSCs for collaborative research studies. To pursue a long-standing interest in iPSC-derived immune cell therapy, she worked in Industry as an R&D scientist at Fate Therapeutics and Century Therapeutics to differentiate and characterize iPSC-derived T cells. From 2023-2024 she took a career break to pursue long-distance backpacking and explore the western US. Going forward as a staff scientist in the Roth and Satpathy labs, Katherine is excited to apply scalable genome perturbations to iPSCs and iPSC-derived lineages to explore novel cell states.

Back to front

Ansu Satpathy, M.D., Ph.D., is a physician-scientist and Associate Professor of Pathology and Immunology at Stanford University. He is the founding director of the Stanford Center for Immunotherapy Design, co-director of the Parker Institute for Cancer Immunotherapy, and co-leader of the Stanford Cancer Institute Immunotherapy Program. Ansu’s research combines expertise in immunology, high-throughput genomics, and computation to discover principles of the immune system in health and disease and to translate these discoveries into novel clinical therapeutics. Ansu holds a BS in molecular biology and BA in philosophy from the University of Illinois, an MD and PhD in immunology from Washington University in St.Louis, and completed his clinical residency and postdoctoral training in genetics at Stanford University.

Back to front

Back to front

Oliver is a graduate student in the Immunology program. As an undergraduate at Tufts, he studied DNA repair of trinucleotide repeat tracts using Baker’s yeast as a model. Prior to graduate school, he spent several years at ArsenalBio developing cell therapies. Oliver hopes to leverage functional genomics and gene editing tools to further understand and manipulate T cell phenotypes. Outside of lab, you may find him biking in the Bay Area or skiing in Tahoe.

Back to front

Lujing is a Life Science Research Professional in the Satpathy lab at the Stanford University School of Medicine. Lujing graduated from the University of California, San Diego with a Bachelor’s Degree in Human biology and a Master’s Degree in Biology. At UCSD, he worked on the role of RNA methylation in cancer progression and cancer immunotherapy, as well as developing CAR-NK cell therapies against solid tumors. At Stanford, he is interested in using pooled genetic screens to explore novel gene candidates that improves CAR-T cell efficacy against cancer.

Back to front

Pat is a graduate student in the Stanford Immunology program. He graduated from Penn State with a bachelor’s in Chemistry in 2016. After graduation, he studied the mechanisms of immune checkpoint blockade therapy in melanoma patients in the lab of Dr. John Wherry. He then worked on transcriptional control of CAR T cells at ArsenalBio. Pat currently focuses on understanding the molecular and signaling events that regulate T cell memory fate decisions. Outside of the lab he enjoys searching the California coast for rocks to climb.

Back to front

Winnie is a Life science research professional 3 (LSRP3) in Satpathy lab in the Department of Pathology. She obtained her Bachelor Degree from UC Berkeley in 2016. Before joining the Satpathy lab, she worked as a LSRP1 in Mark M. Davis lab in the Department of Microbiology and Immunology.

Back to front

Jennifer received her Ph.D. degree from Washington University in St. Louis in 2025. While at WashU, she worked in the Stewart Lab to study breast cancer tumor microenvironment. Her work emphasized understanding how tumor stroma, specifically senescent cancer-associated fibroblasts, modulate tumor immunity and promote breast cancer tumorigenesis. Prior to her graduate school training, Jennifer obtained her B.A. degree from Colby College, where she worked in the Millard Lab and focused on determining how carcinogen-DNA adducts impact human polymerase beta’s function. As a postdoctoral fellow in the Satpathy Lab, Jennifer is interested in applying single-cell and spatial genomics to study how tumors reprogram stromal compartments to escape from immunosurveillance and establish metastasis.

Back to front

Yajie is a Life science research professional 1 (LSRP1) in Satpathy lab in the Department of Pathology. Yajie obtained her Bachelor Degree of Clinical Medicine, evaluated as MD, from Weifang Medical University China in 2013, and received the Master degree in Oncology in 2017. From 2015 to 2019, she worked on Gynecology Oncology in Dr. Bae-Jump lab as a Visiting Scholar & Research Assistant at the University of North Carolina at Chapel Hill. She continued to explore her study on clinical research and received the Master Degree in Biomedical and Translational Science from University of California, Irvine, in 2020. Before joining Satpathy lab, she worked as a Clinical Research Coordinator Assistant in UC Irvine Medical Center. 

Back to front

Marie is a visiting research scholar in cancer immunogenomics from the Samuels Lab at the Weizmann Institute of Science. She earned her master’s degree in Life Science engineering at HTW Berlin and completed her thesis at ZHAW Zurich. Following graduate school, Marie joined Prof. Mitch Levesque’s research group at the University of Zurich, focusing on targeting TRK receptors in melanoma and validating amyloid analogues for the treatment of metastatic melanoma.

At the Satpathy Lab, Marie is leveraging a large-scale CRISPR/Cas9 screen to investigate the effect of cancer-specific dysregulated translation fidelity on immune interactions, aiming to identify novel immunotherapy targets.

Back to front

Royce is an Internal Medicine Resident in the Molecular Medicine Program at UCSF, where he is fast-tracked into Gastroenterology Fellowship. He completed his MD PhD at the Icahn School of Medicine at Mount Sinai where he studied microenvironment controlled super-enhancers in colorectal carcinoma. He is broadly interested in the epigenomics and transcriptional regulation of complex cancer and immune phenotypes, cancer metabolism, and gastrointestinal epithelial cancers. Previously, he graduated from Columbia University where he worked on the epigenetics of cocaine addiction with Nobel Laureate Dr. Eric Kandel.

Back to front